Docetaxel chemotherapy combined with androgen-deprivation therapy in high-volume disease-metastatic hormone-sensitive prostate cancer：an efficacy and safety analysis

doi:10.3969/j.issn.1672-8467.2020.05.015

GUO Zhui-feng, HE Chang, LU Xu-wei, YANG Fan, WU Jia-wen, WANG Hang

Fudan University Journal of Medical Sciences ›› 2020, Vol. 47 ›› Issue (05) : 745-749.

PDF(669 KB)

Fudan University Journal of Medical Sciences ›› 2020, Vol. 47 ›› Issue (05) : 745-749. DOI: 10.3969/j.issn.1672-8467.2020.05.015

Medical Experience Communications

Docetaxel chemotherapy combined with androgen-deprivation therapy in high-volume disease-metastatic hormone-sensitive prostate cancer：an efficacy and safety analysis

{{article.zuoZhe_EN}}

Author information +

History +

HeighLight

Abstract

Key words

QR code of this article

Cite this article

EndNote

Ris (Procite)

Bibtex

Download Citations

{{article.zuoZheEn_L}}. {{article.title_en}}[J]. {{journal.qiKanMingCheng_EN}}, 2020, 47(05): 745-749 https://doi.org/10.3969/j.issn.1672-8467.2020.05.015

References

Publishing order | Descend order by publishing year | Descend order by cited within

References

Funding

RIGHTS & PERMISSIONS

PDF(669 KB)

Accesses

Citation

Detail

Sections

Recommended

Received	Published
2019-12-03	2020-09-25
Issue Date
2020-09-25

Please choose a citation manager

Content to export